Monarch Medical Technologies

Executive Summary

Monarch Medical Technologies is a US-based digital health company that has developed EndoTool®, a patient-specific insulin dosing system for hospital inpatient use. The company's AI-driven algorithm provides precise dosing recommendations for both intravenous and subcutaneous insulin delivery, aiming to improve glycemic management and patient safety. Founded in 2003 and headquartered in Charleston, the company serves healthcare enterprises across the United States, leveraging over two decades of clinical data and algorithmic refinement. EndoTool is designed to reduce hypoglycemic and hyperglycemic events, lower hospital costs, and streamline clinician workflows. With the growing prevalence of diabetes and the need for automated insulin management in hospitals, Monarch is well-positioned to capture market share, though it faces competition from other digital health and medical device companies.

Upcoming Catalysts (preview)

• Q3 2026New hospital system partnerships or contract wins70% success
• Q4 2026Expansion of EndoTool for subcutaneous insulin management60% success
• Q2 2026Peer-reviewed publication of real-world outcomes showing improved glycemic control80% success